{"id":"https://openalex.org/W2136830442","doi":null,"title":"Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.","display_name":"Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs.","alternate_titles":[],"publication_year":2001,"publication_date":"2001-10-16","ids":{"openalex":"https://openalex.org/W2136830442","mag":"2136830442","pmid":"https://pubmed.ncbi.nlm.nih.gov/11699696","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/81535"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:153876","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC81535","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W2136830442"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC81535","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051317639","display_name":"Paul V. Grootendorst","orcid":"https://orcid.org/0000-0003-1978-2834","observed_orcids":["https://orcid.org/0000-0003-1978-2834"]},"institutions":[{"id":"https://openalex.org/I59293822","display_name":"St. Joseph\u2019s Healthcare Hamilton","ror":"https://ror.org/009z39p97","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I59293822"]},{"id":"https://openalex.org/I98251732","display_name":"McMaster University","ror":"https://ror.org/02fa3aq29","country_code":"CA","type":"education","lineage":["https://openalex.org/I98251732"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P V Grootendorst","raw_affiliation_strings":["Department of Clinical Epidemiology and Biostatistics, McMaster University, and Centre for Evaluation of Medicines, St. Joseph's Hospital, Hamilton, Ont. grootend@mcmaster.ca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Epidemiology and Biostatistics, McMaster University, and Centre for Evaluation of Medicines, St. Joseph's Hospital, Hamilton, Ont. grootend@mcmaster.ca","institution_ids":["https://openalex.org/I59293822","https://openalex.org/I98251732"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L R Dolovich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L R Dolovich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012438020","display_name":"Brendan J. O\u2019Brien","orcid":"https://orcid.org/0000-0002-6371-1796","observed_orcids":["https://orcid.org/0000-0002-6371-1796"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B J O'Brien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028992865","display_name":"Anne Marie Holbrook","orcid":"https://orcid.org/0000-0002-3371-4187","observed_orcids":["https://orcid.org/0000-0002-3371-4187"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A M Holbrook","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5012746720","display_name":"Adrian R. Levy","orcid":"https://orcid.org/0000-0002-8966-0966","observed_orcids":["https://orcid.org/0000-0002-8966-0966"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A R Levy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.0076,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.97875753,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"165","issue":"8","first_page":"1011","last_page":"1019"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitrate","display_name":"nitrate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antianginal-drugs","display_name":"antianginal drugs","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.5070000290870667},{"id":"https://openalex.org/keywords/drug-expenditure","display_name":"drug expenditure","score":0.4650000035762787},{"id":"https://openalex.org/keywords/pharmacare","display_name":"pharmacare","score":0.6029999852180481},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nitroglycerin-patch","display_name":"nitroglycerin patch","score":0.9440000057220459},{"id":"https://openalex.org/keywords/sublingual-nitroglycerin","display_name":"sublingual nitroglycerin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.609000027179718},{"id":"https://openalex.org/keywords/british-columbia","display_name":"British Columbia","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.7002067565917969},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6664603352546692},{"id":"https://openalex.org/C84265765","wikidata":"https://www.wikidata.org/wiki/Q193219","display_name":"Subsidy","level":2,"score":0.5468329191207886},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4988083839416504},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4494186043739319},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3933982253074646},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.23096126317977905},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.19589975476264954},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1740173101425171},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17274701595306396},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C34447519","wikidata":"https://www.wikidata.org/wiki/Q179522","display_name":"Market economy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000787","descriptor_name":"Angina Pectoris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001955","descriptor_name":"British Columbia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003363","descriptor_name":"Cost Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005569","descriptor_name":"Formularies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005996","descriptor_name":"Nitroglycerin","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007548","descriptor_name":"Isosorbide Dinitrate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007548","descriptor_name":"Isosorbide Dinitrate","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011306","descriptor_name":"Prescription Fees","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D011306","descriptor_name":"Prescription Fees","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D011907","descriptor_name":"Rate Setting and Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017850","descriptor_name":"Economics, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"pmh:oai:europepmc.org:153876","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC81535","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:81535","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC81535/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CMAJ","raw_type":"Text"},{"id":"pmid:11699696","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11699696","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne","raw_type":"Journal Article"},{"id":"mag:2136830442","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11699696","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.200.6433","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.200.6433","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://collection.nlc-bnc.ca/100/201/300/cdn_medical_association/cmaj/vol-165/issue-8/pdf/pg1011.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:153876","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC81535","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1498161542","https://openalex.org/W1499788840","https://openalex.org/W1949305040","https://openalex.org/W1998744902","https://openalex.org/W2001024656","https://openalex.org/W2007675146","https://openalex.org/W2038515949","https://openalex.org/W2043162683","https://openalex.org/W2056159321","https://openalex.org/W2059679929","https://openalex.org/W2135195489","https://openalex.org/W2168919816","https://openalex.org/W2398117069","https://openalex.org/W2399149723","https://openalex.org/W2408934129","https://openalex.org/W2415397564","https://openalex.org/W2466334522","https://openalex.org/W3024033332","https://openalex.org/W3122523221"],"related_works":["https://openalex.org/W7132957205","https://openalex.org/W2121721478","https://openalex.org/W3122712693","https://openalex.org/W1757527718","https://openalex.org/W7132866389","https://openalex.org/W7133066451","https://openalex.org/W2103071581","https://openalex.org/W7133056454","https://openalex.org/W2148553478","https://openalex.org/W2168919816"],"abstract_inverted_index":{"BACKGROUND:":[0],"Reference-based":[1],"pricing":[2,31,115,136,282],"limits":[3],"reimbursement":[4],"for":[5,36,91,171,219,228,265],"a":[6],"group":[7],"of":[8,18,29,32,41,65,67,103,113,159,190,196,224,240,262,283,290,296],"drugs":[9,34,49,69,206],"that":[10,23,168,207,257,280],"are":[11],"deemed":[12],"therapeutically":[13],"equivalent":[14],"to":[15,51,96,118,144,155,164,254,277,310],"the":[16,19,27,62,71,78,88,92,111,126,130,165,176,181,188,197,238,248,255,260,266],"cost":[17,75],"lowest-priced":[20],"product":[21],"within":[22],"group.":[24],"We":[25,58],"estimated":[26],"effect":[28],"reference-based":[30,114,135,191,241,281],"nitrate":[33,104],"used":[35],"long-term":[37],"prophylaxis":[38],"on":[39,44,141,299],"prescribing":[40],"and":[42,46,70,86,175,306],"expenditures":[43,105,121,140,200,218],"nitrates":[45,142,186,284],"other":[47,220],"anti-anginal":[48,68,221],"dispensed":[50],"senior":[52,108,145,202],"citizens":[53,109,146,203],"in":[54,61,100,217,231],"British":[55],"Columbia.":[56],"METHODS:":[57],"assessed":[59],"trends":[60],"monthly":[63,101],"volume":[64],"prescriptions":[66],"associated":[72,302],"drug":[73,82,267,292],"ingredient":[74],"paid":[76,170],"by":[77,87,148,201],"province's":[79],"publicly":[80],"funded":[81],"subsidy":[83],"program,":[84],"Pharmacare,":[85],"patients":[89,232],"themselves":[90],"period":[93],"April":[94],"1994":[95],"May":[97],"1999.":[98],"Trends":[99],"rates":[102],"per":[106],"100,000":[107],"before":[110,187],"introduction":[112,189,239],"were":[116,162,180,208,213],"extrapolated":[117],"infer":[119],"what":[120],"would":[122],"have":[123],"been":[124],"without":[125],"policy.":[127],"RESULTS:":[128],"During":[129],"3":[131],"1/2":[132],"years":[133],"after":[134,237,268],"was":[137],"introduced,":[138],"Pharmacare":[139,169,258],"prescribed":[143,185,251],"declined":[147],"$14.9":[149],"million":[150,194],"(95%":[151],"confidence":[152],"interval":[153],"$10.7":[154],"$19.1":[156],"million).":[157],"Most":[158],"these":[160],"savings":[161,198],"due":[163],"lower":[166],"prices":[167],"sustained-release":[172],"nitroglycerin":[173,177,244],"tablets":[174],"patch,":[178],"which":[179],"2":[182],"most":[183,249],"frequently":[184,250],"pricing;":[192],"$1.2":[193],"(8%)":[195],"represented":[199],"who":[204],"purchased":[205],"only":[209],"partially":[210],"reimbursed.":[211],"There":[212],"no":[214],"compensatory":[215],"increases":[216],"drugs.":[222],"Use":[223],"sublingual":[225],"nitroglycerin--a":[226],"marker":[227],"deteriorating":[229],"health":[230,303],"with":[233],"angina--did":[234],"not":[235],"increase":[236],"pricing.":[242],"The":[243,294],"patch":[245],"is":[246],"now":[247],"nitrate,":[252],"owing":[253],"fact":[256],"resumed":[259],"provision":[261],"full":[263],"subsidies":[264],"its":[269,287],"manufacturers":[270],"voluntarily":[271],"reduced":[272],"retail":[273],"prices.":[274],"INTERPRETATION:":[275],"Evidence":[276],"date":[278],"suggests":[279],"has":[285],"achieved":[286],"primary":[288],"goal":[289],"reducing":[291],"expenditures.":[293],"effects":[295],"this":[297],"policy":[298],"patient":[300],"health,":[301],"care":[304],"costs":[305,308],"administrative":[307],"remain":[309],"be":[311],"investigated.":[312]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2136830442","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
